Skip to main content Accessibility help

Perimenstrual exacerbation of symptoms in borderline personality disorder: evidence from multilevel models and the Carolina Premenstrual Assessment Scoring System

  • Tory A. Eisenlohr-Moul (a1) (a2), Katja M. Schmalenberger (a3), Sarah A. Owens (a1), Jessica R. Peters (a4), Danyelle N. Dawson (a5) and Susan S. Girdler (a1)...
  • Please note a correction has been issued for this article.



Individuals with a borderline personality disorder (BPD) suffer from a constellation of rapidly shifting emotional, interpersonal, and behavioral symptoms. The menstrual cycle may contribute to symptom instability among females with this disorder.


Fifteen healthy, unmedicated females with BPD and without dysmenorrhea reported daily symptoms across 35 days. Urine luteinizing hormone and salivary progesterone (P4) were used to confirm ovulation and cycle phase. Cyclical worsening of symptoms was evaluated using (1) phase contrasts in multilevel models and (2) the Carolina Premenstrual Assessment Scoring System (C-PASS), a protocol for evaluating clinically significant cycle effects on symptoms.


Most symptoms demonstrated midluteal worsening, a perimenstrual peak, and resolution of symptoms in the follicular or ovulatory phase. Post-hoc correlations with person-centered progesterone revealed negative correlations with most symptoms. Depressive symptoms showed an unexpected delayed pattern in which baseline levels of symptoms were observed in the ovulatory and midluteal phases, and exacerbations were observed during both the perimenstrual and follicular phases. The majority of participants met C-PASS criteria for clinically significant (⩾30%) symptom exacerbation. All participants met the emotional instability criterion of BPD, and no participant met DSM-5 criteria for premenstrual dysphoric disorder (PMDD).


Females with BPD may be at elevated risk for perimenstrual worsening of emotional symptoms. Longitudinal studies with fine-grained hormonal measurement as well as hormonal experiments are needed to determine the pathophysiology of perimenstrual exacerbation in BPD.


Corresponding author

Author for correspondence: Tory A. Eisenlohr-Moul, E-mail:


Hide All
Aviram, RB, Brodsky, BS and Stanley, B (2006) Borderline personality disorder, stigma, and treatment implications. Harvard Review of Psychiatry 14, 249256.
Baer, RA and Sauer, SE (2011) Relationships between depressive rumination, anger rumination, and borderline personality features. Personality Disorders 2, 142150.
Ball, JS and Links, PS (2009) Borderline personality disorder and childhood trauma: evidence for a causal relationship. Springer Current Psychiatry Reports 11, 6368.
Bateman, AW and Fonagy, P (2004) Mentalization-based treatment of BPD. Journal of Personality Disorders 18, 3651.
Beck, AT and Steer, RA (1987) Manual for the Revised Beck Depression Inventory. San Antonio, TX: Psychological Corporation.
Bender, DS, Dolan, RT, Skodol, AE, Sanislow, CA, Dyck, IR, McGlashan, TH, Shea, MT, Zanarini, MC, Oldham, JM and Gunderson, JG (2001) Treatment utilization by patients with personality disorders. The American Journal of Psychiatry 158, 295302.
Ben Dor, R, Harsh, VL, Fortinsky, P, Koziol, DE, Rubinow, DR and Schmidt, PJ (2013) Effects of pharmacologically induced hypogonadism on mood and behavior in healthy young women. The American Journal of Psychiatry 170, 426433.
Bernstein, DP, Fink, L, Handelsman, L, Foote, J, Lovejoy, M, Wenzel, K, Sapareto, E and Ruggiero, J (1994) Initial reliability and validity of a new retrospective measure of child abuse and neglect. The American Journal of Psychiatry 151, 1132.
Bloch, M, Schmidt, PJ, Danaceau, M, Murphy, J, Nieman, L and Rubinow, DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. The American Journal of Psychiatry 157, 924930.
DeSoto, MC (2007) Borderline personality disorder, gender and serotonin: does estrogen play a role? In Czerbaska, MT (ed.), Psychoneuroendocrinology Research Trends 2007. New York: Nova Science Publishers Inc., pp. 149160.
DeSoto, MC, Geary, DC, Hoard, MK, Sheldon, MS and Cooper, L (2003) Estrogen fluctuations, oral contraceptives and borderline personality. Psychoneuroendocrinology 28, 751766.
Edler, C, Lipson, SF and Keel, PK (2007) Ovarian hormones and binge eating in bulimia nervosa. Psychological Medicine 37, 131141.
Eisenlohr-Moul, TA, DeWall, CN, Girdler, SS and Segerstrom, SC (2015) Ovarian hormones and borderline personality disorder features: preliminary evidence for interactive effects of estradiol and progesterone. Biological Psychology 109, 3752.
Eisenlohr-Moul, TA, Rubinow, DR, Schiller, CE, Johnson, JL, Leserman, J and Girdler, SS (2016) Histories of abuse predict stronger within-person covariation of ovarian steroids and mood symptoms in women with menstrually related mood disorder. Psychoneuroendocrinology 67, 142152.
Eisenlohr-Moul, TA, Girdler, SS, Johnson, JL, Schmidt, PJ and Rubinow, DR (2017 a) Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: results of a three-arm randomized controlled trial. Depression and Anxiety 34, 908917.
Eisenlohr-Moul, TA, Girdler, SS, Schmalenberger, KM, Dawson, DN, Surana, P, Johnson, JL and Rubinow, DR (2017b) Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina premenstrual assessment scoring system (C-PASS). The American Journal of Psychiatry 174, 5159.
Endicott, J, Nee, J and Harrison, W (2006) Daily record of severity of problems (DRSP): reliability and validity. Archives of Women's Mental Health 9, 4149.
Epperson, CN, Steiner, M, Hartlage, SA, Eriksson, E, Schmidt, PJ, Jones, I and Yonkers, KA (2012) Premenstrual dysphoric disorder: evidence for a new category for DSM-5. The American Journal of Psychiatry 169, 465475.
First, MB, Spitzer, RL, Gibbons, M, Williams, JBW and Benjamin, L (1996) User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). New York: Biometrics Research Dept, New York State Psychiatric Institute.
Freeman, EW, Halberstadt, SM, Rickels, K, Legler, JM, Lin, H and Sammel, MD (2011) Core symptoms that discriminate premenstrual syndrome. Journal of Women's Health 20, 2935.
Gollenberg, AL, Hediger, ML, Mumford, SL, Whitcomb, BW, Hovey, KM, Wactawski-Wende, J and Schisterman, EF (2010) Perceived stress and severity of perimenstrual symptoms: the BioCycle study. Journal of Women's Health 19, 959967.
Gordon, JL, Girdler, SS, Meltzer-Brody, SE, Stika, CS, Thurston, RC, Clark, CT, Prairie, BA, Moses-Kolko, E, Joffe, H and Wisner, KL (2015) Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. The American Journal of Psychiatry 172, 227236.
Gordon, JL, Rubinow, DR, Eisenlohr-Moul, TA, Leserman, J and Girdler, SS (2016) Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition. Menopause 23, 257266.
Halbreich, U, Endicott, J, Schacht, S and Nee, J (1982) The diversity of premenstrual changes as reflected in the premenstrual assessment form. Acta Psychiatrica Scandinavica 65, 4665.
Hammarbäck, S, Ekholm, UB and Bäckström, T (1991) Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinologica 125, 132137.
Hartlage, SA and Arduino, KE (2002) Toward the content validity of premenstrual dysphoric disorder: do anger and irritability more than depressed mood represent treatment-seekers' experiences? Psychological Reports 90, 189202.
Hartlage, SA, Brandenburg, DL and Kravitz, HM (2004) Premenstrual exacerbation of depressive disorders in a community-based sample in the United States. Psychosomatic Medicine 66, 698706.
Hengartner, MP, Kruger, THC, Geraedts, K, Tronci, E, Mancini, T, Ille, F, Egli, M, Röblitz, S, Ehrig, R, Saleh, L, Spanaus, K, Schippert, C, Zhang, Y and Leeners, B (2017) Negative affect is unrelated to fluctuations in hormone levels across the menstrual cycle: evidence from a multisite observational study across two successive cycles. Journal of Psychosomatic Research 99, 2127.
Hyler, SE, Skodol, AE, Oldham, JM, Kellman, HD and Doidge, N (1992) Validity of the personality diagnostic questionnaire-revised: a replication in an outpatient sample. Comprehensive Psychiatry 33, 7377.
Klump, KL, Keel, PK, Racine, SE, Burt, SA, Burt, AS, Neale, M, Sisk, CL, Boker, S and Hu, JY (2013) The interactive effects of estrogen and progesterone on changes in emotional eating across the menstrual cycle. Journal of Abnormal Psychology 122, 131137.
Leeners, B, Kruger, THC, Geraedts, K, Tronci, E, Mancini, T, Ille, F, Egli, M, Röblitz, S, Saleh, L, Spanaus, K, Schippert, C, Zhang, Y and Hengartner, MP (2017) Lack of associations between female hormone levels and visuospatial working memory, divided attention and cognitive bias across two consecutive menstrual cycles. Frontiers in Behavioral Neuroscience 11, 120.
Linehan, MM (2014) DBT Skills Training Manual, 2nd Edn. New York, NY: Guilford Press.
Linehan, MM, Comtois, KA, Murray, AM, Brown, MZ, Gallop, RJ, Heard, HL, Korslund, KE, Tutek, DA, Reynolds, SK and Lindenboim, N (2006) Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry 63, 757766.
Löfgren, M, Johansson, I-M, Meyerson, B, Turkmen, S and Bäckström, T (2009) Withdrawal effects from progesterone and estradiol relate to individual risk-taking and explorative behavior in female rats. Physiology & Behavior 96, 9197.
Lynam, DR and Widiger, TA (2001) Using the five-factor model to represent the DSM-IV personality disorders: an expert consensus approach. Journal of Abnormal Psychology 110, 401412.
Marschall, D, Sanftner, J and Tangney, JP (1994) The State Shame and Guilt Scale. Fairfax, VA: George Mason University.
Martel, MM, Eisenlohr-Moul, T and Roberts, B (2017) Interactive effects of ovarian steroid hormones on alcohol use and binge drinking across the menstrual cycle. Journal of Abnormal Psychology 126, 1104.
Martinez, PE, Rubinow, DR, Nieman, LK, Koziol, DE, Leslie Morrow, A, Schiller, CE, Cintron, D, Thompson, KD, Khine, KK and Schmidt, PJ (2013) 5α-Reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 41, 10931102.
Morey, LC (2007) Personality Assessment Inventory (PAI): Professional Manual. Odessa, FL: Psychological Assessment Resources.
Nillni, YI, Pineles, SL, Patton, SC, Rouse, MH, Sawyer, AT and Rasmusson, AM (2015) Menstrual cycle effects on psychological symptoms in women with PTSD. Journal of Traumatic Stress 28, 17.
Paris, J and Zweig-Frank, H (2001) A 27-year follow-up of patients with borderline personality disorder. Comprehensive Psychiatry 42, 482487.
Pearlstein, T, Yonkers, KA, Fayyad, R and Gillespie, JA (2005) Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. Journal of Affective Disorders 85, 275282.
Peters, JR, Upton, BT and Baer, RA (2013) Brief report: relationships between facets of impulsivity and borderline personality features. Journal of Personality Disorders 27, 547552.
Peters, JR, Eisenlohr-Moul, TA, Upton, BT, Talavera, NA, Folsom, JJ, Baer, RA (2017) Characteristics of repetitive thought associated with borderline personality features: a multimodal investigation of ruminative content and style. Journal of Psychopathology and Behavioral Assessment 39, 456466.
Putnam, KT, Wilcox, M, Robertson-Blackmore, E, Sharkey, K, Bergink, V, Munk-Olsen, T, Deligiannidis, KM, Payne, J, Altemus, M, Newport, J, Apter, G, Devouche, E, Viktorin, A, Magnusson, P, Penninx, B, Buist, A, Bilszta, J, O'Hara, M, Stuart, S, Brock, R, Roza, S, Tiemeier, H, Guille, C, Epperson, CN, Kim, D, Schmidt, P, Martinez, P, Di Florio, A, Wisner, KL, Stowe, Z, Jones, I, Sullivan, PF, Rubinow, D, Wildenhaus, K, Meltzer-Brody, S, Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium (2017) Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. The Lancet Psychiatry 4, 477485.
Roy-Byrne, PP, Rubinow, DR, Hoban, MC, Parry, BL, Rosenthal, NE, Nurnberger, JI and Byrnes, S (1986) Premenstrual changes: a comparison of five populations. Psychiatry Research 17, 7785.
Saunders, KEA and Hawton, K (2006) Suicidal behaviour and the menstrual cycle. Psychological Medicine 36, 901912.
Schiller, CE, Schmidt, PJ and Rubinow, DR (2014) Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology 231, 35573567.
Schiller, CE, Johnson, SL, Abate, AC, Schmidt, PJ and Rubinow, DR (2016) Reproductive steroid regulation of mood and behavior. Comprehensive Physiology 6, 11351160.
Schmidt, PJ, Nieman, LK, Danaceau, MA, Adams, LF and Rubinow, DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. The New England Journal of Medicine 338, 209216.
Schmidt, PJ, Keenan, PA, Schenkel, LA, Berlin, K, Gibson, C and Rubinow, DR (2013) Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback. Archives of Women's Mental Health 16, 4758.
Schmidt, PJ, Ben Dor, R, Martinez, PE, Guerrieri, GM, Harsh, VL, Thompson, K, Koziol, DE, Nieman, LK and Rubinow, DR (2015) Effects of estradiol withdrawal on mood in women With past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry 72, 714726.
Schwartz, DH, Romans, SE, Meiyappan, S, De Souza, MJ and Einstein, G (2012) The role of ovarian steroid hormones in mood. Hormones and Behavior 62, 448454.
Smith, SS, Ruderman, Y, Frye, C, Homanics, G and Yuan, M (2006) Steroid withdrawal in the mouse results in anxiogenic effects of 3α,5β-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 186, 323333.
Snijders, TA (2005) Power and sample size in multilevel linear models. In Everitt, BS and Howell, DC (eds.), Encyclopedia of Statistics in Behavioral Science, Vol. 3. New York: Wiley, pp. 15701573.
Spielberger, C, Gorsuch, R, Lushene, R, Vagg, P and Jacobs, G (1983) Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press.
Stein, MB, Schmidt, PJ, Rubinow, DR and Uhde, TW (1989) Panic disorder and the menstrual cycle: panic disorder patients, healthy control subjects, and patients with premenstrual syndrome. The American Journal of Psychiatry 146, 12991303.
Stoffel, EC and Craft, RM (2004) Ovarian hormone withdrawal-induced “depression” in female rats. Physiology & Behavior 83, 505513.
Sukhodolsky, DG, Golub, A and Cromwell, EN (2001) Development and validation of the anger rumination scale. Personality and Individual Differences 31, 689700.
Terner, JM and de Wit, H (2006) Menstrual cycle phase and responses to drugs of abuse in humans. Drug and Alcohol Dependence 84, 113.
Ziv, B, Russ, MJ, Moline, M, Hurt, S and Zendell, S (1995) Menstrual cycle influences On mood and behavior in women With borderline personality disorder. Journal of Personality Disorders 9, 6875.


Type Description Title
Supplementary materials

Eisenlohr-Moul et al. supplementary material
Eisenlohr-Moul et al. supplementary material 1

 Word (445 KB)
445 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

A correction has been issued for this article: